These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9790536)

  • 21. Generation of precursor cell lines from preneoplastic fields surrounding head and neck cancers.
    van Zeeburg HJ; Graveland AP; Brink A; Nguyen M; Leemans CR; Bloemena E; Braakhuis BJ; Brakenhoff RH
    Head Neck; 2013 Apr; 35(4):568-74. PubMed ID: 22714984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular changes in the multistage pathogenesis of head and neck cancer.
    Park BJ; Chiosea SI; Grandis JR
    Cancer Biomark; 2010; 9(1-6):325-39. PubMed ID: 22112483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visualization of the timing of gene amplification during multistep head and neck tumorigenesis.
    Roh HJ; Shin DM; Lee JS; Ro JY; Tainsky MA; Hong WK; Hittelman WN
    Cancer Res; 2000 Nov; 60(22):6496-502. PubMed ID: 11103819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The changes and significance of microsatellite loss of heterozygosity in laryngeal premalignant lesions and squamous cell carcinoma].
    Guo T; Sun J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 21(18):831-3. PubMed ID: 18062284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of office examination with narrow band imaging for the diagnosis of head and neck squamous cell carcinoma and follow-up of premalignant lesions.
    Vilaseca I; Valls-Mateus M; Nogués A; Lehrer E; López-Chacón M; Avilés-Jurado FX; Blanch JL; Bernal-Sprekelsen M
    Head Neck; 2017 Sep; 39(9):1854-1863. PubMed ID: 28640478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Essentials of oral cancer.
    Rivera C
    Int J Clin Exp Pathol; 2015; 8(9):11884-94. PubMed ID: 26617944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents.
    Lingen MW
    Crit Rev Oral Biol Med; 1999; 10(2):153-64. PubMed ID: 10759419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
    Young MR; Levingston CA; Johnson SD
    Int J Cancer; 2016 May; 138(10):2487-98. PubMed ID: 26756968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head and neck cancer and precancer: can we use molecular genetics to make better predictions?
    Partridge M
    Ann R Coll Surg Engl; 1999 Jan; 81(1):1-11. PubMed ID: 10325677
    [No Abstract]   [Full Text] [Related]  

  • 30. PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.
    Miyahara LAN; Pontes FSC; Burbano RMR; Conte Neto N; Guimarães DM; Fonseca FP; Pontes HAR
    Histopathology; 2018 Jan; 72(2):330-338. PubMed ID: 28858374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of head and neck cancer.
    Deshpande AM; Wong DT
    Expert Rev Anticancer Ther; 2008 May; 8(5):799-809. PubMed ID: 18471051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.
    Mao L; El-Naggar AK; Papadimitrakopoulou V; Shin DM; Shin HC; Fan Y; Zhou X; Clayman G; Lee JJ; Lee JS; Hittelman WN; Lippman SM; Hong WK
    J Natl Cancer Inst; 1998 Oct; 90(20):1545-51. PubMed ID: 9790547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.
    Shin DM; Kim J; Ro JY; Hittelman J; Roth JA; Hong WK; Hittelman WN
    Cancer Res; 1994 Jan; 54(2):321-6. PubMed ID: 8275461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma.
    Abou-Elhamd KE; Habib TN
    Oral Oncol; 2007 Apr; 43(4):366-72. PubMed ID: 16931118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of p53 protein is common in premalignant head and neck lesions.
    Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE
    Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma.
    Partridge M; Pateromichelakis S; Phillips E; Emilion G; Langdon J
    Clin Cancer Res; 2001 Jul; 7(7):1860-6. PubMed ID: 11448897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular medicine. The forests, trees, and leaves.
    Ensley JF
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1173-7. PubMed ID: 8217074
    [No Abstract]   [Full Text] [Related]  

  • 38. Human Papillomavirus Genotype Association With Survival in Head and Neck Squamous Cell Carcinoma.
    Bratman SV; Bruce JP; O'Sullivan B; Pugh TJ; Xu W; Yip KW; Liu FF
    JAMA Oncol; 2016 Jun; 2(6):823-6. PubMed ID: 27010835
    [No Abstract]   [Full Text] [Related]  

  • 39. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer.
    Mithani SK; Taube JM; Zhou S; Smith IM; Koch WM; Westra WH; Califano JA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4331-5. PubMed ID: 17671113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
    Rubin Grandis J; Tweardy DJ; Melhem MF
    Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.